XTANDI (Enzalutamide 40mg) is a prescription medicine used to treat men with prostate cancer that:
No longer responds to a hormone therapy or surgical treatment to lower testosterone or has spread to other parts of the body and responds to a hormone therapy or surgical treatment to lower testosterone. It is not known if XTANDI is safe and effective in females or children. XTANDI is an androgen receptor inhibitor. Androgens are a group of hormones that includes testosterone. Androgen receptor inhibitors interfere with the connection between androgens and androgen receptors. This can help slow cancer cell growth